These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 16720412)
1. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers. Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412 [TBL] [Abstract][Full Text] [Related]
2. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms. Zhu Y; Mehta KA; McGinity JW Pharm Dev Technol; 2006; 11(3):285-94. PubMed ID: 16895839 [TBL] [Abstract][Full Text] [Related]
3. Crystal growth formation in melt extrudates. Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578 [TBL] [Abstract][Full Text] [Related]
4. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation. Sarode AL; Sandhu H; Shah N; Malick W; Zia H Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847 [TBL] [Abstract][Full Text] [Related]
5. Solid-state plasticization of an acrylic polymer with chlorpheniramine maleate and triethyl citrate. Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW Int J Pharm; 2002 Jul; 241(2):301-10. PubMed ID: 12100857 [TBL] [Abstract][Full Text] [Related]
6. Influence of methylparaben as a solid-state plasticizer on the physicochemical properties of Eudragit RS PO hot-melt extrudates. Wu C; McGinity JW Eur J Pharm Biopharm; 2003 Jul; 56(1):95-100. PubMed ID: 12837487 [TBL] [Abstract][Full Text] [Related]
7. Extended release delivery system of metoprolol succinate using hot-melt extrusion: effect of release modifier on methacrylic acid copolymer. Sawant KP; Fule R; Maniruzzaman M; Amin PD Drug Deliv Transl Res; 2018 Dec; 8(6):1679-1693. PubMed ID: 29948916 [TBL] [Abstract][Full Text] [Related]
8. Citric acid as a solid-state plasticizer for Eudragit RS PO. Schilling SU; Shah NH; Malick AW; Infeld MH; McGinity JW J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259 [TBL] [Abstract][Full Text] [Related]
9. Influence of thermal processing on the properties of chlorpheniramine maleate tablets containing an acrylic polymer. Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW Pharm Dev Technol; 2002 Nov; 7(4):481-9. PubMed ID: 12503529 [TBL] [Abstract][Full Text] [Related]
10. The manufacture and characterisation of hot-melt extruded enteric tablets. Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604 [TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of ketoprofen hot-melt extruded enteric and sustained-release tablets. Yang R; Wang Y; Zheng X; Meng J; Tang X; Zhang X Drug Dev Ind Pharm; 2008 Jan; 34(1):83-9. PubMed ID: 18214759 [TBL] [Abstract][Full Text] [Related]
12. Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets. Dave VS; Fahmy RM; Bensley D; Hoag SW Drug Dev Ind Pharm; 2012 Oct; 38(10):1240-53. PubMed ID: 22257339 [TBL] [Abstract][Full Text] [Related]
13. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55. Sauer D; Zheng W; Coots LB; McGinity JW Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929 [TBL] [Abstract][Full Text] [Related]
14. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction. Alhnan MA; Basit AW Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685 [TBL] [Abstract][Full Text] [Related]
15. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets. Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547 [TBL] [Abstract][Full Text] [Related]
16. Influence of pH and method of crystallization on the solid physical form of indomethacin. Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728 [TBL] [Abstract][Full Text] [Related]
17. Hot melt extruded transdermal films based on amorphous solid dispersions in Eudragit RS PO: The inclusion of hydrophilic additives to develop moisture-activated release systems. Albarahmieh E; Qi S; Craig DQM Int J Pharm; 2016 Nov; 514(1):270-281. PubMed ID: 27863672 [TBL] [Abstract][Full Text] [Related]
19. Influence of plasticizer type and level on the properties of Eudragit S100 matrix pellets prepared by hot-melt extrusion. Schilling SU; Lirola HL; Shah NH; Waseem Malick A; McGinity JW J Microencapsul; 2010; 27(6):521-32. PubMed ID: 20575612 [TBL] [Abstract][Full Text] [Related]
20. Influence of lidocaine forms (salt vs. freebase) on properties of drug-eudragit® L100-55 extrudates prepared by reactive melt extrusion. Liu X; Ma X; Kun E; Guo X; Yu Z; Zhang F Int J Pharm; 2018 Aug; 547(1-2):291-302. PubMed ID: 29883791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]